SLILATY STEVE N. (Chief Executive Officer) purchased 333.3% of their position (100K shares) of SUNSHINE BIOPHARMA INC. on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/5/2024ACC: 0001683168-24-001322
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+100K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Series B Preferred Stock
Direct
Shares
+100K
Price / share
$0.10
Trade value
$10K
% of position
333.3%
3/4/2024
30K→130K
Total
Net shares
+100K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | 3/4/2024 | P · Purchase | +100K | $0.10 | $10K | 333.3% | 30K | 130K |
| Total | +100K | $10K | ||||||
Derivative Transactions0
No derivative transactions reported